showed a trendp = 0.011
While Q2 and Q3 showed a trend toward lower mortality risk compared to Q1, only Q3 reached statistical significance in Model 3 (HR = 0.737, 95% CI: 0.583–0.931, p = 0.011), suggesting a dose–response relationship primarily driven by higher adherence to MDS.